Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants-Reference-Cited by-全球学者库

Heterologous booster with inhaled adenovirus vector COVID-19 vaccine generated more neutralizing antibodies against different SARS-CoV-2 variants

Published:2022-11-04 Issue:1 Volume:11 Page:2689-2697
ISSN:2222-1751
Container-title:Emerging Microbes & Infections
language:en
Short-container-title:Emerging Microbes & Infections

Author:

Zhong Jiaying¹²,Liu Shuo³,Cui Tingting¹²,Li Jingxin⁴,Zhu Fengcai⁴^ORCID,Zhong Nanshan¹²,Huang Weijin³^ORCID,Zhao Zhuxiang⁵,Wang Zhongfang¹²

Affiliation:

1. State Key Laboratory of Respiratory Disease & National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, People’s Republic of China

2. Guangzhou Laboratory, Guangzhou, People’s Republic of China

3. National Institutes for Food and Drug Control, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products & NMPA Key Laboratory for Quality Research and Evaluation of Biological Products Beijing, Beijing, People’s Republic of China

4. NHC Key Laboratory of Enteric Pathogenic Microbiology, Jiangsu Provincial Center for Disease Control and Prevention, Nanjing, People’s Republic of China

5. Department of Infectious Disease, Respiratory and Critical Care Medicine, Guangzhou First People’s Hospital, Guangzhou Medical University, Guangzhou, People’s Republic of China

Funder

State Key Basic Research Project

Ministry of Science and Technology of China

NSFC

Guangdong Key Basic Research Project

Emergency Key Program of Guangzhou Laboratory

Publisher

Informa UK Limited

Subject

Virology,Infectious Diseases,Drug Discovery,General Medicine,Immunology,Microbiology,Parasitology,Epidemiology

Link

https://www.tandfonline.com/doi/pdf/10.1080/22221751.2022.2132881

Reference21 articles.

1. Why does the Omicron sub-variant spread faster than the original?

2. Coronavirus disease (COVID-19): weekly epidemiological update. 2022. Available from: https://reliefweb.int/report/world/coronavirus-disease-covid-19-weekly-epidemiological-update-29-june-2022.

3. Control CfD, Prevention. Centers for disease control and prevention COVID data tracker: vaccination demographics trends. 2021.

4. SARS-CoV-2 spike L452R variant evades cellular immunity and increases infectivity

5. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dynamic immune landscape in vaccinated-BA.5-XBB.1.9.1 reinfections revealed a 5-month protection-duration against XBB infection and a shift in immune imprinting;eBioMedicine;2024-01

2. Safety and immunogenicity of heterologous boosting with orally administered aerosolized bivalent adenovirus type-5 vectored COVID-19 vaccine and B.1.1.529 variant adenovirus type-5 vectored COVID-19 vaccine in adults 18 years and older: a randomized, double blinded, parallel controlled trial;Emerging Microbes & Infections;2023-12-30

3. Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens;Vaccines;2023-10-12

4. Aerosol Inhalation of Chimpanzee Adenovirus Vectors (ChAd68) Expressing Ancestral or Omicron BA.1 Stabilized Pre–Fusion Spike Glycoproteins Protects Non–Human Primates against SARS-CoV-2 Infection;Vaccines;2023-08-28

5. A China-developed adenovirus vector-based COVID-19 vaccine: review of the development and application of Ad5-nCov;Expert Review of Vaccines;2023-08